1. Home
  2. EEX vs LXEO Comparison

EEX vs LXEO Comparison

Compare EEX & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emerald Holding Inc.

EEX

Emerald Holding Inc.

HOLD

Current Price

$4.77

Market Cap

795.2M

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$10.53

Market Cap

663.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEX
LXEO
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
795.2M
663.5M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
EEX
LXEO
Price
$4.77
$10.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$7.70
$18.90
AVG Volume (30 Days)
147.9K
1.5M
Earning Date
10-31-2025
11-05-2025
Dividend Yield
1.28%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$437,500,000.00
N/A
Revenue This Year
$16.88
N/A
Revenue Next Year
$11.10
N/A
P/E Ratio
$230.57
N/A
Revenue Growth
11.18
N/A
52 Week Low
$3.22
$1.45
52 Week High
$5.45
$10.79

Technical Indicators

Market Signals
Indicator
EEX
LXEO
Relative Strength Index (RSI) 61.40 63.02
Support Level $4.53 $9.04
Resistance Level $5.24 $10.56
Average True Range (ATR) 0.37 0.61
MACD 0.16 0.07
Stochastic Oscillator 72.69 85.78

Price Performance

Historical Comparison
EEX
LXEO

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: